Sarcoma derived from cultured mesenchymal stem cells

Stem Cells

Volumn 25, Issue 2, 2007, Pages 371-379

  Tolar, Jakub ^a,e   Nauta, Alma J ^b   Osborn, Mark J ^a   Mortari, Angela Panoskaltsis ^a   McElmurry, Ron T ^a   Bell, Scott ^a   Xia, Lily ^a   Zhou, Ning ^a   Riddle, Megan ^a   Schroeder, Tania M ^a   Westendorf, Jennifer J ^a   McIvor, R Scott ^a   Hogendoorn, Pancras C W ^b   Szuhai, Karoly ^b   Oseth, LeAnn ^a   Hirsch, Betsy ^a   Yant, Stephen R ^c   Kay, Mark A ^c   Peister, Alexandra ^d   Prockop, Darwin J ^d   Fibbe, Willem E ^b   Blazar, Bruce R ^a   more..

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MMC 366   (United States)

Author keywords

Bone marrow transplantation; DNA transposable elements; Mesenchymal stem cells; Neoplastic cell transformation; Sarcoma

Indexed keywords

FIREFLY LUCIFERASE; RED FLUORESCENT PROTEIN;

ANIMAL CELL; ARTICLE; BIOLUMINESCENCE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; C57BL 6 MOUSE; CELL CULTURE; CELL ISOLATION; CELL LABELING; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SARCOMA; TRANSPOSON; TUMOR CELL; WHOLE BODY IMAGING;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CLONE CELLS; EXTREMITIES; KARYOTYPING; LUCIFERASES; LUMINESCENT PROTEINS; LUNG; LUNG NEOPLASMS; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SARCOMA; WHOLE BODY IMAGING;

ANIMALIA; MURINAE; MUS;

EID: 33846910469     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0620     Document Type: Article

References (51)

1. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970;3:393-403.
2. Ashton BA, Eaglesom CC, Bab I et al. Distribution of fibroblastic colony-forming cells in rabbit bone marrow and assay of their osteogenic potential by an in vivo diffusion chamber method. Calcif Tissue Int 1984;36:83-86.
3. Thomson BM, Bennett J, Dean V et al. Preliminary characterization of porcine bone marrow stromal cells: Skeletogenic potential, colony-forming activity, and response to dexamethasone, transforming growth factor beta, and basic fibroblast growth factor. J Bone Miner Res 1993;8:1173-1183.
4. Hurwitz DR, Kirchgesser M, Merrill W et al. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells. Hum Gene Ther 1997;8:137-156.
5. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
6. Peister A, Mellad JA, Larson BL et al. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004;103:1662-1668.
7. Zuk PA, Zhu M, Mizuno H et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001;7:211-228.
8. Wang JF, Wang LJ, Wu YF et al. Mesenchymal stem/progenitor cells in human umbilical cord blood as support for ex vivo expansion of CD34(+) hematopoietic stem cells and for chondrogenic differentiation. Haematologica 2004;89:837-844.
9. Lazarus HM, Koc ON, Devine SM et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005;11:389-398.
10. Horwitz EM, Prockop DJ, Fitzpatrick LA et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999;5:309-313.
11. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-1441.
12. Jones OY, Steele A, Jones JM et al. Nonmyeloablative bone marrow transplantation of BXSB lupus mice using fully matched allogeneic donor cells from green fluorescent protein transgenic mice. J Immunol 2004;172:5415-5419.
13. Jones OY, Good RA, Cahill RA. Nonmyeloablative allogeneic bone marrow transplantation for treatment of childhood overlap syndrome and small vessel vasculitis. Bone Marrow Transplant 2004;33:1061-1063.
14. El-Badri NS, Maheshwari A, Sanberg PR. Mesenchymal stem cells in autoimmune disease. Stem Cells Dev 2004;13:463-472.
15. Studeny M, Marini FC, Dembinski JL et al. Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004;96:1593-1603.
16. Studeny M, Marini FC, Champlin RE et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002;62:3603-3608.
17. Ivics Z, Hackett PB, Plasterk RH et al. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 1997;91:501-510.
18. Bevis BJ, Glick BS. Rapidly maturing variants of the Discosoma red fluorescent protein (DsRed). Nat Biotechnol 2002;20:83-87.
19. Dupuy AJ, Clark K, Carlson CM et al. Mammalian germ-line transgenesis by transposition. Proc Natl Acad Sci U S A 2002;99:4495-4499.
20. Luo G, Ivics Z, Izsvak Z et al. Chromosomal transposition of a Tc1/ mariner-like element in mouse embryonic stem cells. Proc Natl Acad Sci U S A 1998;95:10769-10773.
21. Yant SR, Meuse L, Chiu W et al. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet 2000;25:35-41.
22. Yant SR, Park J, Huang Y et al. Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: Critical residues for DNA binding and hyperactivity in mammalian cells. Mol Cell Biol 2004;24:9239-9247.
23. Romeo S, Bovee JV, Grogan SP et al. Chondromyxoid fibroma resembles in vitro chondrogenesis, but differs in expression of signalling molecules. J Pathol 2005;206:135-142.
24. Szuhai K, Tanke HJ. COBRA: COmbined Binary RAtio labelling of nucleic acids probes for multi-colour FISH karyotyping. Nature Protocols 2006;1:264-275.
25. Telenius H, Carter NP, Bebb CE et al. Degenerate oligonucleotide-primed PCR: General amplification of target DNA by a single degenerate primer. Genomics 1992;13:718-725.
26. Telenius H, Pelmear AH, Tunnacliffe A et al. Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosomes Cancer 1992;4:257-263.
27. Szuhai K, Bezrookove V, Wiegant J et al. Simultaneous molecular karyotyping and mapping of viral DNA integration sites by 25-color COBRA-FISH. Genes Chromosomes Cancer 2000;28:92-97.
28. Schroeder TM, Kahler RA, Li X et al. Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation. J Biol Chem 2004;279:41998-42007.
29. Collier LS, Carlson CM, Ravimohan S et al. Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature 2005;436:272-276.
30. Dupuy AJ, Akagi K, Largaespada DA et al. Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 2005;436:221-226.
31. Lee RH, Hsu SC, Munoz J et al. A subset of human rapidly self-renewing marrow stromal cells preferentially engraft in mice. Blood 2006;107:2153-2161.
32. Munoz JR, Stoutenger BR, Robinson AP et al. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci U S A 2005;102:18171-18176.
33. Prowse KR, Greider CW. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci U S A 1995;92:4818-4822.
34. Serakinci N, Guldberg P, Burns JS et al. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 2004;23:5095-5098.
35. Prindull G, Zipori D. Environmental guidance of normal and tumor cell plasticity: Epithelial mesenchymal transitions as a paradigm. Blood 2004;103:2892-2899.
36. Greaves M. Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Cancer 1999;35:1941-1953.
37. Houghton J, Stoicov C, Nomura S et al. Gastric cancer originating from bone marrow-derived cells. Science 2004;306:1568-1571.
38. Stark A, Aparisi T, Ericsson JL. Human osteogenic sarcoma: Fine structure of the osteoblastic type. Ultrastruct Pathol 1983;4:311-329.
39. Tabe Y, Konopleva M, Munsell MF et al. PML-RARalpha is associated with leptin-receptor induction: The role of mesenchymal stem cell-derived adipocytes in APL cell survival. Blood 2004;103:1815-1822.
40. Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005;11:321-334.
41. Djouad F, Plence P, Bony C et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003;102:3837-3844.
42. Warner JK, Wang JC, Hope KJ et al. Concepts of human leukemic development. Oncogene 2004;23:7164-7177.
43. Rubio D, Garcia-Castro J, Martin MC et al. Spontaneous human adult stem cell transformation. Cancer Res 2005;65:3035-3039.
44. Mitelman F. Recurrent chromosome aberrations in cancer. Mutat Res 2000;462:247-253.
45. Gorlick R, Anderson P, Andrulis I et al. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: Meeting summary. Clin Cancer Res 2003;9:5442-5453.
46. Willems SM, Debiec-Rychter M, Szuhai K et al. Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model. Mod Pathol 2006;19:407-416.
47. Bovee JV, Cleton-Jansen AM, Taminiau AH et al. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncol 2005;6:599-607.
48. Khanna C, Prehn J, Yeung C et al. An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clin Exp Metastasis 2000;18:261-271.
49. Bell RS, Roth YF, Gebhardt MC et al. Timing of chemotherapy and surgery in a murine osteosarcoma model. Cancer Res 1988;48:5533-5538.
50. Dunn TB, Andervont HB. Histology of some neoplasms and non-neoplastic lesions found in wild mice maintained under laboratory conditions. J Natl Cancer Inst 1963;31:873-901.
51. Choi CH, Sedlacek RS, Suit HD. Radiation-induced osteogenic sarcoma of C3H mouse: Effects of Corynebacterium parvum and WBI on its natural history and response to irradiation. Eur J Cancer 1979;15:433-442.